Abstract

Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension in patients with liver cirrhosis. The exact cardiac consequences of subsequent increase of central blood volume are unknown. Cardiovascular magnetic resonance (CMR) imaging is the method of choice for quantifying cardiac volumes and ventricular function. The aim of this study was to investigate effects of TIPS on the heart using CMR, laboratory, and imaging cardiac biomarkers. 34 consecutive patients with liver cirrhosis were evaluated for TIPS. Comprehensive CMR with native T1 mapping, transthoracic echocardiography, and laboratory biomarkers were assessed before and after TIPS insertion. Follow-up (FU) CMR was obtained in 16 patients (47%) 207 (170–245) days after TIPS. From baseline (BL) to FU, a significant increase of all indexed cardiac chamber volumes was observed (all P < 0.05). Left ventricular (LV) end-diastolic mass index increased significantly from 45 (38–51) to 65 (51–73) g/m2 (P = < 0.01). Biventricular systolic function, NT-proBNP, high-sensitive troponin T, and native T1 time did not differ significantly from BL to FU. No patient experienced cardiac decompensation following TIPS. In conclusion, in patients without clinically significant prior heart disease, increased cardiac preload after TIPS resulted in increased volumes of all cardiac chambers and eccentric LV hypertrophy, without leading to cardiac impairment during follow-up in this selected patient population.

Highlights

  • Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension in patients with liver cirrhosis

  • We investigated the medium-term cardiac effects resulting from hemodynamic changes after TIPS implantation using Cardiovascular magnetic resonance (CMR) and cardiovascular biomarkers

  • Stable right and left ventricular function as well as stable laboratory and imaging biomarkers such as NT-proBNP, high-sensitive Troponin T (hs-TnT), and myocardial native T1 time do not indicate that these cardiac adaptions caused severe myocardial injury with impairment of systolic function in patients with normal Left ventricular (LV) function, no relevant heart valve defects, and a maximum diastolic dysfunction of grade 2

Read more

Summary

Introduction

Transjugular intrahepatic portosystemic shunt (TIPS) reduces portal hypertension in patients with liver cirrhosis. TIPS increases cardiac preload resulting from increased shunting of blood from the splanchnic vascular bed into the central vascular bed and thereby increases the central blood volume and aggravates the hyperdynamic circulation s­ tate[3]. These changes can lead to acute heart failure following TIPS implantation in 0.9 to 20%4,5. Our aim was to characterize how TIPS insertion affects cardiac function in patients with liver cirrhosis in order to identify possible mechanisms leading to post-TIPS heart failure

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call